Privium Fund Management’s Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 BURU.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-185,100
Closed -$4K 128
2023
Q3
$4K Hold
185,100
﹤0.01% 102
2023
Q2
$7.4K Buy
+185,100
New +$9.24K ﹤0.01% 108

Other funds holding BURU.WS

Privium Fund Management's BURU.WS Position: Q4 2023 in Review

Privium Fund Management sold out of Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (BURU.WS) in Q4 2023, closing a stake of 185,100 shares — an estimated $4K sold.

Privium Fund Management first reported a position in BURU.WS in Q2 2023 and held it in 2 quarters. The position peaked at $7.4K in Q2 2023. 5 funds tracked by Wall St. Rank hold BURU.WS as of Q4 2023.

  • Privium Fund Management reported no remaining Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
  • Privium Fund Management sold 185,100 Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q4 2023, an estimated $4K.
  • Privium Fund Management first reported a position in Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q2 2023 and held it in 2 quarters.
  • Privium Fund Management's Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $7.4K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q4 2023.

Based on Privium Fund Management's 13F filing for Q4 2023, filed 13 Feb 2024.